A comprehensive view of Generics / Biosimilars. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FTC files an amicus brief alleging that Teva improperly listed patents on its ProAir HFA asthma inhaler in the FDA Orange Book, blocking Amneal's approval for a generic version; the FTC is seeking a court judgement to make Teva retract the patents

Cardinal Health focuses on biosimilars to lower healthcare costs and revolutionize treatment access; operations consolidate in Central Ohio for better service delivery and market expansion

Biocon Biologics settles patent disputes with Bayer and Regeneron, can launch YESAFILI biosimilar in Canada by July 2025

Celltrion submits BLA for CT-P39, a biosimilar version of Xolair, to US FDA for treatment of multiple conditions including asthma and food allergies; submission backed by data demonstrating comparable efficacy and safety

FDA approves Fresenius Kabi's Tyenne, a biosimilar tocilizumab drug for inflammatory and immune diseases referencing Actemra tocilizumab in both IV and subcutaneous formulations; this marks the company's third biosimilar approval in the US

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count